Open AccessSAT-LB073 SJX-653, a Novel Selective NK3 Antagonist, Demonstrates Activity on Pharmacodynamic Markers of NK3 Target Engagement
Author(s) -
Jennifer Cormier,
Malcolm Boyce,
Frans van den Berg,
Daniel Grau,
David J. Turnquist,
Deya Corzo,
Philip B. Graham
Publication year - 2019
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/js.2019-sat-lb073
Subject(s) - medicine , placebo , pharmacodynamics , tolerability , adverse effect , pharmacokinetics , antagonist , pharmacology , receptor , pathology , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom